Jean-Yves Blay
Director/Board Member at INNATE PHARMA
Net worth: 137 $ as of 30/05/2024
Network origin in Jean-Yves Blay first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 30 | |
20
| Public Company | Biotechnology | 20 |
Université Claude Bernard Lyon 1
4
| College/University | Other Consumer Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Yves Blay via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President | |
IPSEN | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
STALLERGENES | Pharmaceuticals: Major | Director/Board Member Chairman | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
GLENMARK PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOMÉRIEUX | Medical Specialties | Director/Board Member Founder Director/Board Member Director/Board Member Corporate Officer/Principal | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
INSEAD | College/University | Graduate Degree Masters Business Admin | |
University of Milan | College/University | Doctorate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ESSEC Business School | College/University | Masters Business Admin Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Advanced BioScience Laboratories, Inc.
Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Chairman | |
University of Lyon | College/University | Doctorate Degree Undergraduate Degree | |
Biomerieux Pierre Fabre SA
Biomerieux Pierre Fabre SA Medical SpecialtiesHealth Technology Biomerieux Pierre Fabre SA specializes in infectious disease diagnostics. The firm also offers coagulation diagnostics and industrial microbiology controlling services. The company manily focuses in the field of microbiology. It was founded in December, 2000 and is headquartered in Paris, France. | Medical Specialties | Chief Executive Officer Chairman | |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Founder Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO General Counsel | |
Université d'Aix-Marseille | College/University | Chairman Graduate Degree Doctorate Degree | |
Synergie Lyon Cancer
Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Transgene, Inc. | Director/Board Member Director/Board Member | ||
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Miscellaneous Commercial Services | Chairman Chairman Director of Finance/CFO | |
Harvard Business School | College/University | Undergraduate Degree Undergraduate Degree | |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Chairman Chairman | |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
BEIGENE, LTD. | Pharmaceuticals: Major | Director/Board Member | |
GENEURO SA | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Chairman | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S Financial ConglomeratesFinance Novo Nordisk North America Operations A/S is an investment holding Danish company. The company is based in Bagsværd, Denmark. The company was founded in 2011. The CEO is Peter Bøggild. | Financial Conglomerates | Chairman | |
Mérieux NutriSciences Corp.
Mérieux NutriSciences Corp. Miscellaneous Commercial ServicesCommercial Services Mérieux NutriSciences Corp. engages in the provision of scientific service solutions to food industries. It offers offers analytical and product development solutions to prevent health risks related to food and more generally to the use of everyday consumer products. It also offers digital solutions as part of its dedicated business The company was founded by John H. Silliker and Charles M?rieux in 1967 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
France | 25 |
United States | 15 |
United Kingdom | 3 |
Denmark | 3 |
Switzerland | 3 |
Sectoral
Health Technology | 29 |
Consumer Services | 10 |
Commercial Services | 6 |
Finance | 4 |
Health Services | 4 |
Operational
Director/Board Member | 191 |
Corporate Officer/Principal | 94 |
Chairman | 59 |
Independent Dir/Board Member | 47 |
Undergraduate Degree | 31 |
Most connected contacts
Insiders | |
---|---|
Jean-Luc Bélingard | 40 |
Benoît Habert | 34 |
Alain Mérieux | 32 |
Philippe Archinard | 24 |
Patrick J. Langlois | 23 |
Maïlys Ferrère | 21 |
Hervé Eloi Dominique Brailly | 20 |
Olivier Martinez | 19 |
Alessandro Riva | 14 |
Irina Staatz-Granzer | 14 |
Joyson Karakunnel | 14 |
Marie-Yvonne Landel-Meunier | 13 |
Hedi Brahim | 13 |
Sonia Quaratino | 13 |
Karsten Munk Knudsen | 12 |
- Stock Market
- Insiders
- Jean-Yves Blay
- Company connections